New version of Seroquel OKd
AstraZeneca said U.S. regulators had approved a new oncedaily version of its Seroquel schizophrenia drug.
Seroquel is the Londonbased company’s second-biggest-selling drug, with global sales of $3.4 billion last year. Analysts said Food and Drug Administration approval of Seroquel XR was important to extend the life cycle of the family of drugs.
The new version of the drug is under patent until 2017.